| Michigan Senior Mental Health Specialists Llc | |
|
5448 W Farrand Rd Clio MI 48420-8204 | |
| (810) 533-1476 | |
| Not Available |
| Full Name | Michigan Senior Mental Health Specialists Llc |
|---|---|
| Speciality | Social Worker |
| Location | 5448 W Farrand Rd, Clio, Michigan |
| Authorized Official Name and Position | Mary Moritz (OWNER) |
| Authorized Official Contact | 8105331476 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Michigan Senior Mental Health Specialists Llc 5448 W Farrand Rd Clio MI 48420-8204 Ph: (810) 533-1476 | Michigan Senior Mental Health Specialists Llc 5448 W Farrand Rd Clio MI 48420-8204 Ph: (810) 533-1476 |
| NPI Number | 1407631401 |
|---|---|
| Provider Enumeration Date | 08/28/2023 |
| Last Update Date | 08/28/2023 |
| Certification Date | 08/28/2023 |
| Medicare PECOS PAC ID | 5991151961 |
|---|---|
| Medicare Enrollment ID | O20231026003611 |
News Archive
The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published May 2 in the Journal of the National Cancer Institute.
People with "prediabetes" (a high risk state for overt type 2 diabetes) who experience a period of normal glucose regulation are 56% less likely to develop diabetes 5∙7 years later, according to a new research Article presented at the American Diabetes Association 72nd Scientific Sessions on Saturday 9 June, and published Online First in The Lancet. This is one of four Articles (all presented at the American Diabetes Association 72nd Scientific Sessions) and a Series of three papers that are part of a special Lancet theme issue on diabetes [1].
Neogenix Oncology, Inc. announced today that researchers at Duke University Medical Center have received approval to move forward with a Phase I trial of the company's lead therapeutic antibody, NPC-1C, in patients with advanced stage pancreatic or colorectal cancer. Duke joins Johns Hopkins Hospital which is already conducting the Phase I trial of NPC-1C. In addition to Johns Hopkins, North Shore - LIJ has also enrolled patients on this multi-center study.
A serious form of cancer that occurs in some transplant patients may arise because cells that normally serve as scouts for the immune system become weakened, a new study suggests.
Researchers at the London School of Hygiene & Tropical Medicine have created a comic influenced by the Japanese manga style to help busy medical staff who treat patients suffering from bleeding.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407631401 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Mary Moritz |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1629509187 PECOS PAC ID: 3971866351 Enrollment ID: I20180417002721 |
News Archive
The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published May 2 in the Journal of the National Cancer Institute.
People with "prediabetes" (a high risk state for overt type 2 diabetes) who experience a period of normal glucose regulation are 56% less likely to develop diabetes 5∙7 years later, according to a new research Article presented at the American Diabetes Association 72nd Scientific Sessions on Saturday 9 June, and published Online First in The Lancet. This is one of four Articles (all presented at the American Diabetes Association 72nd Scientific Sessions) and a Series of three papers that are part of a special Lancet theme issue on diabetes [1].
Neogenix Oncology, Inc. announced today that researchers at Duke University Medical Center have received approval to move forward with a Phase I trial of the company's lead therapeutic antibody, NPC-1C, in patients with advanced stage pancreatic or colorectal cancer. Duke joins Johns Hopkins Hospital which is already conducting the Phase I trial of NPC-1C. In addition to Johns Hopkins, North Shore - LIJ has also enrolled patients on this multi-center study.
A serious form of cancer that occurs in some transplant patients may arise because cells that normally serve as scouts for the immune system become weakened, a new study suggests.
Researchers at the London School of Hygiene & Tropical Medicine have created a comic influenced by the Japanese manga style to help busy medical staff who treat patients suffering from bleeding.
› Verified 5 days ago
| Provider Name | Paula Lynn Walko |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1093247728 PECOS PAC ID: 6709114069 Enrollment ID: I20190823001927 |
News Archive
The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published May 2 in the Journal of the National Cancer Institute.
People with "prediabetes" (a high risk state for overt type 2 diabetes) who experience a period of normal glucose regulation are 56% less likely to develop diabetes 5∙7 years later, according to a new research Article presented at the American Diabetes Association 72nd Scientific Sessions on Saturday 9 June, and published Online First in The Lancet. This is one of four Articles (all presented at the American Diabetes Association 72nd Scientific Sessions) and a Series of three papers that are part of a special Lancet theme issue on diabetes [1].
Neogenix Oncology, Inc. announced today that researchers at Duke University Medical Center have received approval to move forward with a Phase I trial of the company's lead therapeutic antibody, NPC-1C, in patients with advanced stage pancreatic or colorectal cancer. Duke joins Johns Hopkins Hospital which is already conducting the Phase I trial of NPC-1C. In addition to Johns Hopkins, North Shore - LIJ has also enrolled patients on this multi-center study.
A serious form of cancer that occurs in some transplant patients may arise because cells that normally serve as scouts for the immune system become weakened, a new study suggests.
Researchers at the London School of Hygiene & Tropical Medicine have created a comic influenced by the Japanese manga style to help busy medical staff who treat patients suffering from bleeding.
› Verified 5 days ago
News Archive
The ductal carcinoma in situ Score quantifies the risk of ipsilateral breast event and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to improve the process of selecting individualized treatment for women with DCIS who meet the criteria, according to a study published May 2 in the Journal of the National Cancer Institute.
People with "prediabetes" (a high risk state for overt type 2 diabetes) who experience a period of normal glucose regulation are 56% less likely to develop diabetes 5∙7 years later, according to a new research Article presented at the American Diabetes Association 72nd Scientific Sessions on Saturday 9 June, and published Online First in The Lancet. This is one of four Articles (all presented at the American Diabetes Association 72nd Scientific Sessions) and a Series of three papers that are part of a special Lancet theme issue on diabetes [1].
Neogenix Oncology, Inc. announced today that researchers at Duke University Medical Center have received approval to move forward with a Phase I trial of the company's lead therapeutic antibody, NPC-1C, in patients with advanced stage pancreatic or colorectal cancer. Duke joins Johns Hopkins Hospital which is already conducting the Phase I trial of NPC-1C. In addition to Johns Hopkins, North Shore - LIJ has also enrolled patients on this multi-center study.
A serious form of cancer that occurs in some transplant patients may arise because cells that normally serve as scouts for the immune system become weakened, a new study suggests.
Researchers at the London School of Hygiene & Tropical Medicine have created a comic influenced by the Japanese manga style to help busy medical staff who treat patients suffering from bleeding.
› Verified 5 days ago
Momentum Counseling, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 740 Center St, Clio, MI 48420 Phone: 810-686-7313 | |
Brooke Ashley Counseling, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 740 Center St, Clio, MI 48420 Phone: 810-686-7313 Fax: 810-686-7315 | |
Robin Fenlon Lmsw Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 740 Center St, Clio, MI 48420 Phone: 810-686-7313 Fax: 810-686-7315 | |
C-sam Services & Management Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 740 Center St, Clio, MI 48420 Phone: 810-686-7313 Fax: 810-686-7315 | |
Darden Counseling Services Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 740 Center St, Clio, MI 48420 Phone: 810-686-7313 Fax: 810-686-7315 | |
Res-care Premier, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1220 W Lake Rd, Clio, MI 48420 Phone: 810-686-1393 |